
Anshu Singh
About Anshu Singh
Data last updated:
Anshu Singh has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Equitax Consultants Private Limited and Aurevix Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Equitax Consultants Private Limited at ₹19.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Jul 2018 | 2018 | ₹19.3 Lakh (FY 2025) | Active | |
| Director | 14 Jul 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anshu Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anshu Singh
Anshu Singh has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Equitax Consultants Private Limited and Aurevix Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Equitax Consultants Private Limited at ₹19.3 Lakh (FY 2025).
Anshu Singh is associated with 2 companies as Director, including Equitax Consultants Private Limited (₹19.3 Lakh), Aurevix Lifesciences Private Limited.
Anshu Singh has expertise in General Business.
Anshu Singh has 8 years in corporate governance.
By reported revenue, the largest current company of Anshu Singh is Equitax Consultants Private Limited, with revenue of ₹19.3 Lakh (FY 2025).
Anshu Singh currently holds positions at 2 companies: Equitax Consultants Private Limited (₹19.3 Lakh), Aurevix Lifesciences Private Limited.